Hélène Carvaillo graduated from the engineering school CPE Lyon in 2022. During her studies, she had the opportunity to work at Origenis GmbH in Munich, where she was in charge of the synthesis of bioactive molecules. She then joined a double-diploma program at the University of Würzburg where she studied organic and medicinal chemistry. She completed her master thesis in the MedChem department of Merck KgaA in Darmstadt. She joined the team Amino Acids, Heterocycles, Peptides and Proteins in 2022 for a PhD thesis under the supervision of Pr Nicolas Masurier to develop inhibitors of a serine protease involved in multiple sclerosis disease.